Expert Interview
Understanding the progression of antibiotic resistance, the development of new antibiotics, and the potential of the PASTEUR Act which has been introduced to Congress.
Ticker(s): IBBInstitution: Affiliated with multiple hospitals in the Loma Linda California area
- Hospitalist, Board Certified Family Medicine Doctor with over 17 years of experience in the hospital medicine field.
- Currently manages 20 patients per month with central venous catheters that have developed a CRBSI or CLABSI
- Familiar with the results from the Phase 2b trial which assessed the safety and efficiency of Mino-Lok to salvage central venous catheters from catheter-related bloodstream infections (CRBSIs) and central line associated bloodstream infections (CLABSIs)
What hurdles do you see companies running into in developing new antibiotics?
Added By: max_adminOn a scale of 1-10 how excited are you regarding the PASTEUR act?
Added By: max_adminWhat is the current state of treatments with new resistance developing?
Added By: max_adminDo you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
